Peptide & Oligo CDMO

Complete Lifecycle Manufacturing

Accelerating Large-Scale, Late-Phase Development & Commercial Production

CPC Scientific Scientist - Mobile Header

Peptide & Oligo CDMO

Complete Lifecycle Manufacturing

Accelerating Large-Scale, Late-Phase Development & Commercial Production

Peptide & Oligo CDMO Services

Research Peptides

CPC Scientific is one of the premier custom peptide producers in the world and we are proud to offer consistently reliable, high-quality peptides directly to researchers.

GMP Peptides

Large-scale manufacturing capacity to support your GMP projects at every stage, from early discovery and late-phase development to full commercialization.

Oligonucleotides

We provide research-grade and clinical-grade oligonucleotide manufacturing services to our clients spanning from discovery to clinical phases.

Peptide-Oligo Conjugates

Our peptide-oligonucleotide conjugate (POC) services seamlessly integrate our peptide and oligonucleotide platforms.

Trusted Peptide & Oligo Manufacturer

With 25 years of expertise, our group is a globally recognized and leading CDMO specializing in peptide and oligonucleotide production. We work directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market.

300+

NCE & Generic Projects

13

Commercial GMP Projects

>1T

Annual Production Capacity

Featured News & Articles

4Nov 2025

CPC Scientific: Peptide & Oligonucleotide CDMO By the Numbers Infographic

November 4th, 2025|Brochure Request, Brochures, Featured News|

Discover how CPC Scientific has earned the trust of top pharma and biotech companies across 50+ countries. See the numbers behind our track record as a leading peptide and oligonucleotide CDMO partner, including 300+ ongoing CMC development projects, 13 commercial GMP manufacturing programs, 25 years of global operations, 500+ employees, and more.

Upcoming Events

  • RNA Leaders USA Congress 2025 in Boston Massachusetts

    Boston, MA | Sept. 23-25, 2026

    RNA Leaders is the #1 must-attend event focused on RNA medicines such as RNAi, antisense, non-linear RNAs, RNA editing and targeting RNA, as well as manufacturing development of mRNA therapies and vaccines.

  • CPC Scientific attends BioJapan 2026 in Yokohama Japan

    Yokohama, Japan | October 7-9, 2026

    Launched in 1986, BioJapan is Asia's premier bio-industry partnering event. As the world’s longest-running biotech exhibition, BioJapan continues to drive innovation and collaboration in the industry through its comprehensive event ecosystem, seminars, and partnering programs.

White Papers

Recent Publications and Citations

What Clients Say About Working With CPC Scientific

White Medtide Inc. Logo

Medtide Inc. Stock

Parent Company of CPC Scientific
(HKEX: 3880.HK)

Parent Company of CPC Scientific
(HKEX: 3880.HK)
White Medtide Inc. Logo
Go to Top